Biomimetic protein nanoparticles facilitate enhanced dendritic cell activation and cross-presentation.
about
Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and ImmunotherapyImmunomodulation of nanoparticles in nanomedicine applicationsHigh-Density Lipoproteins: Nature's Multifunctional NanoparticlesThe Effect of Superparamagnetic Iron Oxide Nanoparticle Surface Charge on Antigen Cross-PresentationA Modular Vaccine Development Platform Based on Sortase-Mediated Site-Specific Tagging of Antigens onto Virus-Like ParticlesViral-mimicking protein nanoparticle vaccine for eliciting anti-tumor responses.Engaging adaptive immunity with biomaterialsCaged protein nanoparticles for drug delivery.Protein nanoparticles for therapeutic protein delivery.Engineered Materials for Cancer Immunotherapy.Modifying the tumor microenvironment using nanoparticle therapeuticsEmerging nanotechnologies for cancer immunotherapyGold nanocluster-based vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides.Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy?Iron oxide superparamagnetic nanoparticles conjugated with a conformationally blocked α-Tn antigen mimetic for macrophage activation.Mechanisms allowing protein delivery in nasal mucosa using NPL nanoparticles.Display of DNA on Nanoparticles for Targeting Antigen Presenting Cells.Co-delivery of human cancer-testis antigens with adjuvant in protein nanoparticles induces higher cell-mediated immune responses.Strong in vivo antitumor responses induced by an antigen immobilized in nanogels via reducible bonds.Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment.Sortase A-mediated multi-functionalization of protein nanoparticles.Vaccination with trifunctional nanoparticles that address CD8+ dendritic cells inhibits growth of established melanoma.Designing biomaterials with immunomodulatory properties for tissue engineering and regenerative medicine.Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer ImmunotherapyProtein Nanoparticles as Multifunctional Biocatalysts and Health Assessment Sensors
P2860
Q26782566-80582672-4FD4-4BA5-BD27-E3A5640A6DC2Q27021145-C060BD65-03A6-4EA6-B565-B2F8BAFEEFFCQ28077290-465DF3FD-B21F-417D-A5D6-2F80EF2C77C5Q28818748-21057F8D-F4CF-4D5B-B847-0497DC76A1F7Q28834387-E31ABFCF-41DF-46F8-B28D-5E4376797FDFQ36642808-47B192F3-9AA5-49F2-8606-85BC899BEA0EQ37691850-2B191B3B-1B40-44B4-88A7-C0950DBAC3ADQ38212056-476AC24D-C72F-40AB-A08A-27978EAD64D1Q38556744-03375CA1-19E3-49D7-B0A8-CC3F81562FCFQ38660577-75CB6400-49BF-4958-A2AC-85C8FA2F8639Q38796320-62395D99-FB18-4670-B642-62F516934D49Q38837036-A42376D0-5F7C-4ECF-B32F-1BD06AD6CD72Q38858337-0F2E963C-8B48-4BDD-9448-32FD1A0B23C3Q38912004-A33A0EF0-93DF-4326-AC5F-B1C2EDC9190EQ38988340-78C52487-5278-4B0B-9090-79E9D72F6700Q40713612-8188E758-74C4-4CFA-BAB2-C9E9D08F56E5Q42099934-8D87F0C7-A0BC-479C-BBA9-22C2F6214BB3Q46193557-C15745C8-632B-40B0-AE5F-1B014BB49352Q48974238-90363E8A-747A-40E1-B5BB-63A07ECED03EQ49391681-EA6A43E1-9369-47DA-975A-616C74A89E20Q50959169-54D4B674-B477-44A1-BDFC-59CBF339D3EAQ52848957-ADD27561-D6BB-4BFD-9D70-C2FC5D71037BQ53064170-936E116F-4D59-4172-9790-98DF23091EA0Q57492118-B6D0DA95-26B0-458F-A121-2FC545E74E39Q58134759-95E42C01-1A6E-4CFF-8E13-3E540C5F5F92
P2860
Biomimetic protein nanoparticles facilitate enhanced dendritic cell activation and cross-presentation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biomimetic protein nanoparticl ...... vation and cross-presentation.
@en
Biomimetic protein nanoparticl ...... vation and cross-presentation.
@nl
type
label
Biomimetic protein nanoparticl ...... vation and cross-presentation.
@en
Biomimetic protein nanoparticl ...... vation and cross-presentation.
@nl
prefLabel
Biomimetic protein nanoparticl ...... vation and cross-presentation.
@en
Biomimetic protein nanoparticl ...... vation and cross-presentation.
@nl
P2093
P2860
P356
P1433
P1476
Biomimetic protein nanoparticl ...... vation and cross-presentation.
@en
P2093
Amanda K L Anderson
Nicholas M Molino
Szu-Wen Wang
P2860
P304
P356
10.1021/NN403085W
P407
P577
2013-10-09T00:00:00Z